Tech Company Financing Transactions

Amyris Funding Round

On 2/2/2015, Amyris secured $21.7 million in funding from private investors.

Transaction Overview

Company Name
Announced On
2/2/2015
Transaction Type
Debt
Amount
$21,700,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing - amended. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.

Company Information

Company Status
Publicly-held
Industry
Clean Tech
Mailing Address
5885 Hollis St. 100
Emeryville, CA 94608
USA
Email Address
Not Recorded
Overview
Amyris is a renewable products company applying our inspired science to deliver sustainable solutions for a growing world.
Profile
Amyris LinkedIn Company Profile
Social Media
Amyris Company Twitter Account
Company News
Amyris News
Facebook
Amyris on Facebook
YouTube
Amyris on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Melo
  John Melo LinkedIn Profile  John Melo Twitter Account  John Melo News  John Melo on Facebook
Chief Financial Officer
Kathleen Valiasek
  Kathleen Valiasek LinkedIn Profile  Kathleen Valiasek Twitter Account  Kathleen Valiasek News  Kathleen Valiasek on Facebook
Chief Operating Officer
Eduardo Alvarez
  Eduardo Alvarez LinkedIn Profile  Eduardo Alvarez Twitter Account  Eduardo Alvarez News  Eduardo Alvarez on Facebook
VP - Bus. Development
Caroline Hadfield
  Caroline Hadfield LinkedIn Profile  Caroline Hadfield Twitter Account  Caroline Hadfield News  Caroline Hadfield on Facebook
VP - Human Resources
Christine Ofori
  Christine Ofori LinkedIn Profile  Christine Ofori Twitter Account  Christine Ofori News  Christine Ofori on Facebook
VP - Manufacturing
Charles Kraft
  Charles Kraft LinkedIn Profile  Charles Kraft Twitter Account  Charles Kraft News  Charles Kraft on Facebook
VP - Product Management
James Iacoponi
  James Iacoponi LinkedIn Profile  James Iacoponi Twitter Account  James Iacoponi News  James Iacoponi on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/2/2015: ALTATHERA Pharmaceuticals venture capital transaction
Next: 2/2/2015: Genomind venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary